For breast cancer susceptibility, genetic testing generally focuses on high-risk genes, notably BRCA1, BRCA2, PALB2, and TP53, but testing of larger panels that include so-called “moderate-risk” genes is being increasingly offered [1]. The gene discussed is BRCA2; the disease is breast carcinoma.